-
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
19 Feb 2026 12:00 GMT
… and strategic finance roles at Forest Laboratories, Inc. and Regeneron Pharmaceuticals, Inc … Company is also advancing a drug discovery program to identify novel …
-
Recent Rulings Highlight Risk to Japanese Drugmakers in Settling Pharmaceutical Litigations
01 Nov 2025 23:18 GMT
… . 4th 223 (2d Cir. 2024). Forest Laboratories, the brand manufacturer of Bystolic … United States are aggressively attacking drug settlements that provide value to … entry of generic competition. Japanese drug manufacturers should carefully review these …
-
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
17 Feb 2026 12:00 GMT
… Received Positive Pre-Investigational New Drug (“IND”) Written Feedback from … a past board member of Forest Laboratories, Ironwood Pharmaceuticals, Axovant Sciences … on topics including controlled drug delivery, pharmacokinetics, drug metabolism, and clinical …
-
Tariffs set to hit Ireland, where US drugmakers play tax games
19 Aug 2025 09:09 GMT
… of cancer medications, weight-loss drug ingredients and other pharmaceutical products … of cancer medications, weight-loss drug ingredients and other pharmaceutical products … lower their overall tax bill.
Forest Laboratories, now owned by AbbVie, shifted …
-
<![CDATA[European Biotechs Impacting Treatment of Alzheimer’s Disease]]>
12 Feb 2026 18:16 GMT
… AD treatments, such as Forest Laboratories' orally active Namenda … the US Food and Drug Administration (FDA) accepted the … pathways, to help align drug development and investment in … al. Alzheimer’s Disease Drug Development Pipeline: 2025. Alzheimer …
-
P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease
04 Jun 2025 22:32 GMT
COI Statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the the Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Switzerland and …
-
Polaryx Therapeutics Welcomes New Members of the Board of Directors
05 Feb 2026 13:30 GMT
… Chief Intellectual Property Counsel at Forest Laboratories (now AbbVie) for more than … of LSDs. Our small molecule drug candidates share similar modes of …
-
Global Angina Pectoris Treatment Market Report 2022 to 2030 - Featuring Forest Laboratories, Gilead Sciences, GlaxoSmithKline, Novartis and Pfizer Among Others - ResearchAndMarkets.com
31 Jan 2023 14:56 GMT
… pipeline analysis of upcoming potential drugs.
Companies Profiled
Abbott Laboratories Inc … F. Hoffmann-La Roche Ltd.
Forest Laboratories Inc.
Gilead Sciences, Inc.
GlaxoSmithKline … pectoris treatment market comprises potential drugs which are specific and fast …
-
Global Substance Abuse Treatment Market Report to 2030 - Featuring Alkermes, Allergan, Forest Laboratories and GlaxoSmithKline Among Others
30 Jan 2023 10:25 GMT
… market segments based on drug class and different geographical … use of habit forming drugs or substances; leading to … rise in the number of drug addicted population, increased government … 4. Strategic Initiatives
10.3. Forest Laboratories, Inc.
10.3.1. …
-
Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med
07 Jul 2024 22:44 GMT
… makes Sanofi and Regeneron Pharmaceuticals drug Dupixent the first biologic … his career, Rowe worked at Forest Laboratories, which developed roflumilast, approved by … require hospitalization. Results showed the drug, administered as a subcutaneous injection …
About
© 1995-2026